First in class.
Soares
Christine
C
D001552:Benzazepines / Q000009:adverse effects*; D006801:Humans; D011605:Psychoses, Substance-Induced; D011810:Quinoxalines / Q000009:adverse effects*; D011978:Receptors, Nicotinic; D012640:Seizures / Q000139:chemically induced; D016540:Smoking Cessation; D014481:United States; D014486:United States Food and Drug Administration; D000068580:Varenicline
D001552:Benzazepines; D011810:Quinoxalines; D011978:Receptors, Nicotinic; D000068580:Varenicline